Clinical Trial Update: A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing Follitropin alfa solution in a pen to Follitropin alfa powder in a vial in healthy downregulated male participants; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Follitropin alfa (folitropin alfa)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Hypogonadism | Phase 1 | Status: COMPLETED